Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ...
Pharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 million Cash and cash equivalents of $75.7 million as of December 31, 2024 ...
Medicinal Mushroom Market Medicinal Mushroom Market Research Report Information By Type, By Form, By Function And By Region –Market Forecas ...
Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 ...
Cosmetics Market Cosmetics Market Research Report Information By Product Type, By Category, By Distribution Channel, And By Region NEW ...